Innosis Ecological Ag News - IVX

Re Agreement

IVAX Corporation, Miami David Malina, 305-575-6043 IVAX And Alpharma Reach Agreement On Metformin ER IVAX Corporation (AMEX:IVX) (LSE:IVX.L) has...

IVAX Receives Tentative Approval For Gabapentin

IVAX Corporation, Miami David Malina, 305/575-6043 IVAX Corporation (AMEX:IVX) (LSE:IVX.L) has received tentative approval from the FDA for its...

U.S. District Court Extends TRO Against FDA Until November 26th

IVAX Corporation, Miami David Malina, 305-575-6043 Director/Investor Relations & Corporate Communications IVAX Corporation (AMEX:IVX)(LSE:IVX.L...

U.S. District Court Extends TRO Against FDA Until November 21st

IVAX Corporation David Malina, 305-575-6043 IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that the U.S. District Court in Washington D.C. has...

IVAX To Present At CIBC World Markets Fourteenth Annual Healthcare Conference

IVAX Corporation David Malina, 305-575-6043 Director/Investor Relations & Corporate Communications IVAX Corporation (AMEX:IVX) (LSE:IVX.L) is...

Directorate Change

IVAX Corporation, Miami David Malina, 305-575-6043 IVAX Names Ambassador Paul L. Cejas And Bruce W. Greer To Board Of Directors IVAX Corporation...

IVAX Reports 3rd Quarter Results and Gives Guidance for 2004; IVAX Anticipates Meeting or Exceeding Consensus Estimates for 2004

IVAX Corporation Thomas Beier, 305-575-6563 or David Malina, 305-575-6043 IVAX Corporation (AMEX:IVX)(LSE:IVX.L) reported third quarter 2003 net...

IVAX Confident ''First to File'' Status and Final Approval on Metformin ER Will Be Upheld

IVAX Corporation David Malina, 305-575-6043 IVAX Corporation (AMEX:IVX)(LSE:IVX.L) said that Alpharma, Inc. (NYSE:ALO) brought legal action in...

IVAX First To File For Metformin ER Tablet And FDA Grants Final Approval

IVAX Corporation IVAX Corporation (AMEX:IVX) (LSE:IVX.L) received final approval and confirmation of its first to file status from the FDA today...

IVAX Provides October 30th Third Quarter 2003 Financial Results Conference Call And Website Information

IVAX Corporation, Miami David Malina, 305/575-6043 IVAX Corporation (AMEX:IVX)(LSE:IVX.L) will release its third quarter 2003 financial results...

Response to - IVAX Responds to First to File Reports-Metformin ER

IVAX Corporation David Malina, 305/575-6043 IVAX Responds To First To File Reports On Metformin ER In response to reports citing that IVAX...

Further re - IVAX Confirms Consummation of 3M Transaction

IVAX Corporation As previously announced on Oct. 1, 2003, IVAX Corporation (AMEX:IVX) (LSE:IVX.L) has consummated its agreement with the 3M...

IVAX To Release Third Quarter Financial Results October 30th

IVAX CorporationIVAX Corporation (AMEX:IVX) (LSE:IVX.L) plans to release its third quarter 2003 financial results on Thursday, October 30th before...

Re Agreement

IVAX Corporation IVAX/3M Transaction Completed: Respiratory Products Franchise And Sales Force In Europe Expanded IVAX Corporation (AMEX:IVX...

Regulatory Approval

IVAX Corporation, Miami David Malina, 305-575-6043 Director/Investor Relations & Corporate Communications IVAX Receives Tentative Approval For...

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Innosis Ecological Ag (IVX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

IVX News

Re Agreement

IVAX Receives Tentative Approval For Gabapentin

U.S. District Court Extends TRO Against FDA Until November 26th

U.S. District Court Extends TRO Against FDA Until November 21st

IVAX To Present At CIBC World Markets Fourteenth Annual Healthcare Conference

Directorate Change

IVAX Reports 3rd Quarter Results and Gives Guidance for 2004; IVAX Anticipates Meeting or Exceeding Consensus Estimates for 2004

IVAX Confident ''First to File'' Status and Final Approval on Metformin ER Will Be Upheld

IVAX First To File For Metformin ER Tablet And FDA Grants Final Approval

IVAX Provides October 30th Third Quarter 2003 Financial Results Conference Call And Website Information

Response to - IVAX Responds to First to File Reports-Metformin ER

Further re - IVAX Confirms Consummation of 3M Transaction

IVAX To Release Third Quarter Financial Results October 30th

Re Agreement

Regulatory Approval

IVX Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Innosis Ecological Ag (IVX) News

Innosis Ecological Ag (IVX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

IVX News

Re Agreement

IVAX Receives Tentative Approval For Gabapentin

U.S. District Court Extends TRO Against FDA Until November 26th

U.S. District Court Extends TRO Against FDA Until November 21st

IVAX To Present At CIBC World Markets Fourteenth Annual Healthcare Conference

Directorate Change

IVAX Reports 3rd Quarter Results and Gives Guidance for 2004; IVAX Anticipates Meeting or Exceeding Consensus Estimates for 2004

IVAX Confident ''First to File'' Status and Final Approval on Metformin ER Will Be Upheld

IVAX First To File For Metformin ER Tablet And FDA Grants Final Approval

IVAX Provides October 30th Third Quarter 2003 Financial Results Conference Call And Website Information

Response to - IVAX Responds to First to File Reports-Metformin ER

Further re - IVAX Confirms Consummation of 3M Transaction

IVAX To Release Third Quarter Financial Results October 30th

Re Agreement

Regulatory Approval

IVX Discussion

Your Recent History

Company

Business

Popular

Get The App